Rita Dhar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rita Dhar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Wadha Alfouzan
Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya 46300, Kuwait
4 shared publications - Walid Q. Alali
Department of Biostatistics & Epidemiology, College of Public Health, East Tennessee State University, Johnson City, USA
3 shared publications - Ali A. Rabaan
Alfaisal University
2 shared publications Mona Badawi
Department of Pediatrics, Al-Adan Hospital, Hadiya, Kuwait
2 shared publicationsZahra Qabazard
Department of Pediatrics, Al-Adan Hospital, Hadiya, Kuwait
2 shared publicationsAbdul Hafez Othman
Maternity Hospital
1 shared publication
Latest Publications
- Open Access
Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait
We sought to assess pre-vaccination and post-vaccination seroprevalences of anti-SARS-CoV-2 antibodies in Kuwait and to compare antibody levels between vaccine types. In phase 1 (pre-vaccination period, n = 19,363), blood samples were collected before the launch of COVID-19 vaccination in Kuwait between 1 September and 31 December 2020. Blood samples for phase 2 (post-vaccination period, n = 4973) were collected between 1 September and 30 November 2021. We tested subjects for anti-SARS-CoV-2 antibodies using the DiaSorin LIAISON® SARS-CoV-2 IgM and Trimeric S IgG tests. In the pre-vaccination period, the prevalence of SARS-CoV-2 IgM and IgG was 14.50% (95% CI: 14.01–15.00) and 24.89% (95% CI: 24.29–25.50), respectively. The trend of seropositivity increased with age and was higher for females and non-Kuwaiti participants (p < 0.0001). Interestingly, seroprevalence was significantly higher for those who had received one dose of BNT162b2 (95.21%) than those who had received one dose of ChAdOx1-nCov-19 (92.86%). In addition, those who reported receiving two doses had higher seroprevalence, 96.25%, 95.86%, and 94.93% for ChA-dOx1-nCov-19/AstraZeneca, mix-and-match, and BNT162b2 recipients, respectively. After the second dose, median spike-specific responses showed no significant difference between ChAdOx1-nCov-19 and BNT162b2. Furthermore, statistical analysis showed no significant difference between median anti-trimeric S antibody levels of vaccinated individuals according to sex, age, or nationality (p > 0.05). In contrast, a negative correlation between age and anti-trimeric S IgG titers of BNT162b2-vaccinated subjects was observed (r = −0.062, p = 0.0009). Antibody levels decreased with time after vaccination with both vaccines. Our findings indicate that seroprevalence was very low during the pre-vaccination period (25%) in the general population and was greater than 95% in the vaccinated population in Kuwait. Furthermore, ChAdOx1-nCov-19 and BNT162b2 are effective in generating a similar humoral response.
Open AccessChanging Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait
We sought to assess pre-vaccination and post-vaccination seroprevalences of anti-SARS-CoV-2 antibodies in Kuwait and to compare antibody levels between vaccine types. In phase 1 (pre-vaccination period, n = 19,363), blood samples were collected before the launch of COVID-19 vaccination in Kuwait between 1 September and 31 December 2020. Blood samples for phase 2 (post-vaccination period, n = 4973) were collected between 1 September and 30 November 2021. We tested subjects for anti-SARS-CoV-2 antibodies using the DiaSorin LIAISON® SARS-CoV-2 IgM and Trimeric S IgG tests. In the pre-vaccination period, the prevalence of SARS-CoV-2 IgM and IgG was 14.50% (95% CI: 14.01–15.00) and 24.89% (95% CI: 24.29–25.50), respectively. The trend of seropositivity increased with age and was higher for females and non-Kuwaiti participants (p < 0.0001). Interestingly, seroprevalence was significantly higher for those who had received one dose of BNT162b2 (95.21%) than those who had received one dose of ChAdOx1-nCov-19 (92.86%). In addition, those who reported receiving two doses had higher seroprevalence, 96.25%, 95.86%, and 94.93% for ChA-dOx1-nCov-19/AstraZeneca, mix-and-match, and BNT162b2 recipients, respectively. After the second dose, median spike-specific responses showed no significant difference between ChAdOx1-nCov-19 and BNT162b2. Furthermore, statistical analysis showed no significant difference between median anti-trimeric S antibody levels of vaccinated individuals according to sex, age, or nationality (p > 0.05). In contrast, a negative correlation between age and anti-trimeric S IgG titers of BNT162b2-vaccinated subjects was observed (r = −0.062, p = 0.0009). Antibody levels decreased with time after vaccination with both vaccines. Our findings indicate that seroprevalence was very low during the pre-vaccination period (25%) in the general population and was greater than 95% in the vaccinated population in Kuwait. Furthermore, ChAdOx1-nCov-19 and BNT162b2 are effective in generating a similar humoral response.
- Open Access
Infection Control Measures against Candidaauris in Healthcare Facilities
Candida auris is an emerging multidrug-resistant yeast with high mortality rate, especially in patients with underlying co-morbidities. It has been known to contaminate the environment and colonize human skin for prolonged periods in healthcare settings leading to difficult-to-control outbreaks. However, there is limited literature on the efficacy of different disinfectants/antiseptics, which can effectively decontaminate the environment and decolonize patients to prevent the spread of C. auris. This review highlights recommendations available in the literature for detection and control of C. auris in healthcare settings. Detection of C. auris by biochemical and automated methods has often been misleading. Availability of C. auris-specific PCR can prove to be a more reliable technique for detection of C. auris. Control measures for transmission of C. auris include use of registered hospital grade disinfectant active against Clostridium difficile cleaning the environment and equipment and chlorhexidine for decolonization of patients. Hand hygiene using soap and water, followed by use of alcohol-based hand sanitizer for maximal disinfection, is recommended for healthcare workers.
Open AccessInfection Control Measures against Candidaauris in Healthcare Facilities
Candida auris is an emerging multidrug-resistant yeast with high mortality rate, especially in patients with underlying co-morbidities. It has been known to contaminate the environment and colonize human skin for prolonged periods in healthcare settings leading to difficult-to-control outbreaks. However, there is limited literature on the efficacy of different disinfectants/antiseptics, which can effectively decontaminate the environment and decolonize patients to prevent the spread of C. auris. This review highlights recommendations available in the literature for detection and control of C. auris in healthcare settings. Detection of C. auris by biochemical and automated methods has often been misleading. Availability of C. auris-specific PCR can prove to be a more reliable technique for detection of C. auris. Control measures for transmission of C. auris include use of registered hospital grade disinfectant active against Clostridium difficile cleaning the environment and equipment and chlorhexidine for decolonization of patients. Hand hygiene using soap and water, followed by use of alcohol-based hand sanitizer for maximal disinfection, is recommended for healthcare workers.
- Open Access
- 1 June 2021
- Published by Elsevier in Journal of Clinical Virology Plus
- Vol. 1 (1-2) , 100017
Severe acute respiratory syndrome coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait
- 1 June 2021
- Published by Elsevier in Journal of Clinical Virology Plus
- Vol. 1 (1-2) , 100017
Open AccessSevere acute respiratory syndrome coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait
- Open Access
- 21 November 2020
- Published by MDPI AG in Journal of Fungi
- Vol. 6 (4) , 307
Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait
The emerging, often multidrug-resistant Candida auris is increasingly being associated with outbreaks in healthcare facilities. Here we describe the molecular epidemiology of a C. auris outbreak during 18 months, which started in 2018 in the high dependency unit (HDU) of a secondary-care hospital in Kuwait. Demographic and clinical data for candidemia and colonized patients were prospectively recorded. Clinical and environmental isolates were subjected to phenotypic and molecular identification; antifungal susceptibility testing by broth microdilution method; PCR-sequencing of ERG11 and FKS1 for resistance mechanisms to triazoles and echinocandins, respectively; and molecular fingerprinting by short tandem repeat (STR) analyses. Seventy-one (17 candidemic and 54 colonized) patients including 26 with candiduria and seven environmental samples yielded C. auris. All isolates were identified as C. auris by Vitek2, MALDI-TOF MS, PCR amplification and/or PCR-sequencing of rDNA. Twelve candidemia and 26 colonized patients were admitted or exposed to HDU. Following outbreak recognition, an intensive screening program was instituted for new patients. Despite treatment of all candidemia and 36 colonized patients, 9 of 17 candidemia and 27 of 54 colonized patients died with an overall crude mortality rate of ~50%. Nearly all isolates were resistant to fluconazole and contained the Y132F mutation in ERG11 except one patient’s isolates, which were also distinct by STR typing. Only urine isolates from two patients developed echinocandin resistance with concomitant FKS1 mutations. The transmission of C. auris in this outbreak was linked to infected/colonized patients and the hospital environment. However, despite continuous surveillance and enforcement of infection control measures, sporadic new cases continued to occur, challenging the containment efforts.
- 21 November 2020
- Published by MDPI AG in Journal of Fungi
- Vol. 6 (4) , 307
Open AccessMolecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait
The emerging, often multidrug-resistant Candida auris is increasingly being associated with outbreaks in healthcare facilities. Here we describe the molecular epidemiology of a C. auris outbreak during 18 months, which started in 2018 in the high dependency unit (HDU) of a secondary-care hospital in Kuwait. Demographic and clinical data for candidemia and colonized patients were prospectively recorded. Clinical and environmental isolates were subjected to phenotypic and molecular identification; antifungal susceptibility testing by broth microdilution method; PCR-sequencing of ERG11 and FKS1 for resistance mechanisms to triazoles and echinocandins, respectively; and molecular fingerprinting by short tandem repeat (STR) analyses. Seventy-one (17 candidemic and 54 colonized) patients including 26 with candiduria and seven environmental samples yielded C. auris. All isolates were identified as C. auris by Vitek2, MALDI-TOF MS, PCR amplification and/or PCR-sequencing of rDNA. Twelve candidemia and 26 colonized patients were admitted or exposed to HDU. Following outbreak recognition, an intensive screening program was instituted for new patients. Despite treatment of all candidemia and 36 colonized patients, 9 of 17 candidemia and 27 of 54 colonized patients died with an overall crude mortality rate of ~50%. Nearly all isolates were resistant to fluconazole and contained the Y132F mutation in ERG11 except one patient’s isolates, which were also distinct by STR typing. Only urine isolates from two patients developed echinocandin resistance with concomitant FKS1 mutations. The transmission of C. auris in this outbreak was linked to infected/colonized patients and the hospital environment. However, despite continuous surveillance and enforcement of infection control measures, sporadic new cases continued to occur, challenging the containment efforts.
- 29 March 2013
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 81 (2) , 191-192
Bacteremia Caused by Rhizobium radiobacter in a Preterm Neonate
The authors report a case of bacteremia due to Rhizobium radiobacter in a preterm neonate. Although the baby recovered from the septic episode following therapy with appropriate antibiotics he succumbed to complications, mainly associated with prematurity. This case highlights a rare manifestation of R.radiobacter infection in a neonate in whom the source of the organism remained undiscovered.
- 29 March 2013
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 81 (2) , 191-192
Bacteremia Caused by Rhizobium radiobacter in a Preterm Neonate
The authors report a case of bacteremia due to Rhizobium radiobacter in a preterm neonate. Although the baby recovered from the septic episode following therapy with appropriate antibiotics he succumbed to complications, mainly associated with prematurity. This case highlights a rare manifestation of R.radiobacter infection in a neonate in whom the source of the organism remained undiscovered.
- 31 December 2004
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (4) , 287-289
Vibrio cholerae (non-O1, non-O139) sepsis in a child with Fanconi anemia
- 31 December 2004
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (4) , 287-289
Vibrio cholerae (non-O1, non-O139) sepsis in a child with Fanconi anemia
- Open Access
- 1 September 2001
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 10 (3) , 123-128
Present Status of Antimicrobial Susceptibility of Haemophilus influenzae Isolates in Kuwait as Determined by E-Test
Objective: To study antimicrobial susceptibility pattern of clinical isolates of Haemophilus influenzae using E-test and compare the results with those of a study done in 1983. Methods: The antimicrobial susceptibility of 196 isolates of H. influenzae against nine antimicrobial agents (amoxicillin-clavulanic acid, ampicillin, cefaclor, cefotaxime, ceftriaxone, chloramphenicol, ciprofloxacin, clarithromycin, and trimethoprim-sulfamethoxazole) was performed by E-test on Haemophilus test medium. The results obtained were compared with those from an earlier study conducted here on 108 strains collected between October and December 1983. Results: Except for cefotaxime, which consistently showed an excellent in vitro activity (MIC90 = 0.047 mg/l), other antimicrobial agents presented a decline in their effectiveness. Among the newer antibiotics tested, all the strains were found to be sensitive to ciprofloxacin (MIC range = 0.004–0.0094 mg/l) whereas clarithromycin showed high MIC of 12 mg/l for 90% of the strains. There was a marked increase in the number of beta-lactamase-producing isolates from 4.6% in 1983 to 31.6% in the present study. Amongst 62 beta-lactamase-producing strains 14.5% exhibited resistance to amoxicillin-clavulanic acid (MIC >8 mg/l). Only 3.1% isolates were found to be of capsular type b in 1998 compared to 9.2% in 1983. No beta-lactamase-negative ampicillin-resistant (BLNAR) strain was isolated during the present study whereas only one strain (0.9%) was isolated in 1983. Conclusion: This study shows that despite a decrease in the number of type b and BLNAR H. influenzae isolates, there is an apparent increase in the trend to acquire resistance to several antimicrobial agents.
- 1 September 2001
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 10 (3) , 123-128
Open AccessPresent Status of Antimicrobial Susceptibility of Haemophilus influenzae Isolates in Kuwait as Determined by E-Test
Objective: To study antimicrobial susceptibility pattern of clinical isolates of Haemophilus influenzae using E-test and compare the results with those of a study done in 1983. Methods: The antimicrobial susceptibility of 196 isolates of H. influenzae against nine antimicrobial agents (amoxicillin-clavulanic acid, ampicillin, cefaclor, cefotaxime, ceftriaxone, chloramphenicol, ciprofloxacin, clarithromycin, and trimethoprim-sulfamethoxazole) was performed by E-test on Haemophilus test medium. The results obtained were compared with those from an earlier study conducted here on 108 strains collected between October and December 1983. Results: Except for cefotaxime, which consistently showed an excellent in vitro activity (MIC90 = 0.047 mg/l), other antimicrobial agents presented a decline in their effectiveness. Among the newer antibiotics tested, all the strains were found to be sensitive to ciprofloxacin (MIC range = 0.004–0.0094 mg/l) whereas clarithromycin showed high MIC of 12 mg/l for 90% of the strains. There was a marked increase in the number of beta-lactamase-producing isolates from 4.6% in 1983 to 31.6% in the present study. Amongst 62 beta-lactamase-producing strains 14.5% exhibited resistance to amoxicillin-clavulanic acid (MIC >8 mg/l). Only 3.1% isolates were found to be of capsular type b in 1998 compared to 9.2% in 1983. No beta-lactamase-negative ampicillin-resistant (BLNAR) strain was isolated during the present study whereas only one strain (0.9%) was isolated in 1983. Conclusion: This study shows that despite a decrease in the number of type b and BLNAR H. influenzae isolates, there is an apparent increase in the trend to acquire resistance to several antimicrobial agents.
- Open Access
- 1 September 2000
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 9 (3) , 198-204
Outcome of Treatment of Haemophilus influenzae Meningitis in Children Complicated by Febrile Episodes
Aim: In this retrospective study, 20 cases of Haemophilus influenzae type b (Hib) meningitis were analysed to assess the outcome of treatment. Methods: Bacteriologically proven cases of meningitis due to Hib were included in this study. The clinical and relevant laboratory data were retrieved from the hospital files. Results: Thirteen patients were treated with a combination of cefotaxime and ampicillin, 4 with cefotaxime, 2 with ceftriaxone and 1 with a combination of ampicillin and chloramphenicol. Only 9 children received concomitant dexamethasone. Nine (45%) cases experienced permanent defervescence within 4 days of admission and were discharged from the hospital after an average stay of 10.5 days. The overall rates of secondary (25%), persistent (5%) and prolonged fever (25%) were observed with an average number of days in hospital of 20.4, 20.0 and 22.8, respectively. Conclusion: Although there was no mortality, there is still a need for appropriate short-duration therapy which will help in bringing about a decline in febrile episodes, thereby reducing cost of management and hospital stay.
- 1 September 2000
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 9 (3) , 198-204
Open AccessOutcome of Treatment of Haemophilus influenzae Meningitis in Children Complicated by Febrile Episodes
Aim: In this retrospective study, 20 cases of Haemophilus influenzae type b (Hib) meningitis were analysed to assess the outcome of treatment. Methods: Bacteriologically proven cases of meningitis due to Hib were included in this study. The clinical and relevant laboratory data were retrieved from the hospital files. Results: Thirteen patients were treated with a combination of cefotaxime and ampicillin, 4 with cefotaxime, 2 with ceftriaxone and 1 with a combination of ampicillin and chloramphenicol. Only 9 children received concomitant dexamethasone. Nine (45%) cases experienced permanent defervescence within 4 days of admission and were discharged from the hospital after an average stay of 10.5 days. The overall rates of secondary (25%), persistent (5%) and prolonged fever (25%) were observed with an average number of days in hospital of 20.4, 20.0 and 22.8, respectively. Conclusion: Although there was no mortality, there is still a need for appropriate short-duration therapy which will help in bringing about a decline in febrile episodes, thereby reducing cost of management and hospital stay.